Clinical characteristics and outcomes according to IBD-like endoscopic pattern
| Characteristic | Crohn’s colitisN = 39 | Ulcerative colitisN = 76 | P value |
|---|---|---|---|
| Duration of symptoms (days, SD) | |||
| IV steroids, n (%) | 19 (61.3) | 49 (75.4) | 0.229 |
| Infliximab/vedolizumab, n (%) | 12 (37.5) | 29 (42.0) | 0.828 |
| Duration from onset to recurrence (days, SD) | 159 (158) | 112 (118) | 0.358 |
| Duration of steroid (days, SD) | 70 (117) | 60 (43) | 0.529 |
| Diarrhea grade, n (%) | 0.118 | ||
| 1 | 5 (12.8) | 5 (6.6) | |
| 2 | 145 (35.9) | 18 (23.7) | |
| 3–4 | 20 (51.3) | 53 (69.7) | |
| Colitis grade, n (%) | 0.201 | ||
| 1 | 7 (17.9) | 5 (6.6) | |
| 2 | 16 (41.0) | 36 (47.4) | |
| 3–4 | 16 (41.0) | 35 (46.1) | |
| High-risk endoscopic features | 23 (59.0) | 48 (63.2) | 0.689 |
| Active histologic inflammation | 33 (84.6) | 67 (88.2) | 0.574 |
| Outcomes, n (%) | |||
| Hospitalization | 30 (76.9) | 65 (85.5) | 0.301 |
| Duration of hospitalization (days) | 8 (6) | 8 (7) | 0.855 |
| ICU admission | 2 (5.1) | 3 (3.9) | 1.000 |
| Recurrence | 15 (38.5) | 16 (21.1) | 0.074 |
| Repeat endoscopy | 12 (30.8) | 15 (19.7) | 0.245 |
Abbreviation: ICU intensive care unit, IV intravenous, SD standard deviation